Compare INLF & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INLF | EVGN |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Agricultural Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 10.9M |
| IPO Year | 2025 | N/A |
| Metric | INLF | EVGN |
|---|---|---|
| Price | $0.61 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 538.5K | 48.2K |
| Earning Date | 09-29-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,332,282.00 | $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 33.11 | 7.19 |
| 52 Week Low | $0.54 | $0.95 |
| 52 Week High | $21.00 | $2.42 |
| Indicator | INLF | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 45.46 |
| Support Level | $0.54 | $1.03 |
| Resistance Level | $0.74 | $1.14 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 51.01 | 42.31 |
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.